A new study of 16,000+ men being treated for prostate cancer demonstrated that those who got any kind of androgen deprivation therapy had nearly twice the risk of developing Alzheimer’s over the next 2 ½ years as men getting other treatments. The result, based on the men’s medical records, is only a correlation, and not proof of causality, but is prompting cancer researchers to look more closely.
Links to the study and to articles about the study have been posted in Risk Factors:
Common Prostate Cancer Treatment May Double Risk for Alzheimer’s
Common prostate cancer treatment may double Alzheimer’s risk
Original article:
Androgen Deprivation Therapy and Future Alzheimer’s Disease Risk [Abstract free; Full text: Paywall]
